The FDA approved the use of Synjardy® XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes.  SYNJARDY XR, from Boehringer Ingelheim and Eli Lilly and Company, is indicated to improve blood sugar in adults with type 2 diabetes when used along with diet and exercise and when both empagliflozin and metformin can be taken.